This advanced technology is specifically tailored for individuals with high power prescriptions, aiming to free the 18-35 age group from the reliance on eyeglasses
Take proper precautions and seek timely treatment!
The strategic acquisition demonstrates the company’s commitment to increasing OTC consumer convenience in eye care
_256_384.jpg)
The collaboration aims to raise awareness about eye cancer, provide medical and surgical treatment support to children and supply nutritional supplements to aid in their faster recovery.
Introduces a line-up of brands targeting key therapeutic categories for its ophthalmology segment launc
The YP-P10 pre-clinical head-to-head study, jointly conducted by five people including Dr. Kyungho Park of Naason Science
CEQUA is the first dry eye treatment available in India that is delivered with nanomicellar (NCELL) technology
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
The new facility will be able to handle four times as many patients as the previous facility.
Subscribe To Our Newsletter & Stay Updated
